Key result
A 62-year-old woman with cardiac amyloidosis presented with tricuspid and mitral stenosis mimicking rheumatic heart disease and was treated with melphalan/dexamethasone chemotherapy.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Cardiac amyloidosis can rarely present with bi-valvular involvement mimicking rheumatic heart disease, highlighting the importance of multimodality imaging in diagnosis.
A 62-year-old woman who had suffered from dyspnoea on exertion was referred to our hospital. She had no past or family history of medical illnesses. Chest X-ray showed mild cardiomegaly. Serum creatinine and brain natriuretic peptide level were mildly elevated as 1.66 mg/dL and 1,418 ng/L, respectively. Although left ventricular (LV) ejection fraction was preserved, thickened LV myocardium with a restrictive LV filling pattern, suggesting restrictive cardiomyopathy, was noted on echocardiography (Panel A and see Supplementary data online, Video S1). Notably, tricuspid valve was thickened and stenotic, accompanied by mitral stenosis, which could be usually seen in rheumatic heart disease (Panels B–D and see Supplementary data online, Video S2). T2-weighted magnetic resonance imaging showed no LV myocardial oedema. Subendocardial and diffuse transmural late gadolinium enhancement and a marked expansion of extracellular space on pre- and post-T1 maps, suggesting cardiac amyloidosis, were shown (Panels E and F and see Supplementary data online, Video S3). A cardiac biopsy showed Congo red-positive with apple-green birefringence under polarized light (Panel G). Finally, under the diagnosis of cardiac amyloidosis with bi-valvular involvement, she was treated with melphalan/dexamethasone chemotherapy.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2014) conducted a case report in Cardiac amyloidosis (n=1). Melphalan/dexamethasone chemotherapy was evaluated. A 62-year-old woman with cardiac amyloidosis presented with tricuspid and mitral stenosis mimicking rheumatic heart disease and was treated with melphalan/dexamethasone chemotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: